28 September 2020 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in MRI-guided ablation products, is pleased to announce the Rhön Clinic Bad Neustadt Campus in Bad Neustadt an der Saale, Germany has signed a purchase agreement with Imricor. The Company is working with the site to schedule installation, training, and first procedures.
Professor Thomas Deneke, Head of Cardiac Rhythm and Interventional Electrophysiology at the Bad Neustadt Campus commented: “We are very excited to have taken this important step toward individualised ablation treatment for our patients with zero-fluoroscopy iCMR-guided catheter ablation.”
Imricor’s Chair and CEO, Steve Wedan, said: “The team and I are extremely pleased to be working with Professor Deneke to bring iCMR ablations to Bavaria. We look forward to working with his world class team at this impressive site, ushering in the new age of interventional electrophysiology guided by MRI and growing it to its full potential.”